Medicare Enrolled
Dr. Irma Castro, MD
Family Medicine · Fresno, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Castro from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Castro?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Castro
Dr. Irma Castro is a family medicine specialist in Fresno, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Castro performed 928 Medicare services across 679 unique beneficiaries.
Between the years covered by Open Payments, Dr. Castro received a total of $15,783 from 65 pharmaceutical and/or device companies across 778 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Castro is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 24% volume in CA
$15,783 industry payments
Medicare Practice Summary
Medicare Utilization ↗928
Medicare services
Top 24% in CA for family medicine
679
Unique beneficiaries
$49
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~49 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
182 | $77 | $160 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
165 | $47 | $113 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
111 | $123 | $168 |
| Annual depression screening | 102 | $17 | $25 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
89 | $0 | $5 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
71 | $29 | $40 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
54 | $72 | $80 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
47 | $9 | $45 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
27 | $14 | $20 |
| COVID-19 amplified DNA/RNA probe detection A laboratory test that uses amplified DNA or RNA probes to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) antigen. |
18 | $45 | $52 |
| Quadrivalent influenza vaccine, preservative-free A flu shot containing four strains of the influenza virus, formulated without preservatives, administered in a 0.5 ml dose. |
18 | $22 | $49 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
17 | $3 | $18 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
15 | $3 | $13 |
| Routine 12-lead ECG screening A standard 12-lead electrocardiogram performed as part of an initial preventive physical examination. The service includes both the performance of the test and the physician's interpretation and report. |
12 | $9 | $52 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$15,783
Total received (2018-2024)
Avg $2,255/year across 7 years
Top 2% in CA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
65
Companies
778
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,677 (99.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$106 (0.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,746
2023
$1,993
2022
$1,925
2021
$3,199
2020
$1,678
2019
$2,919
2018
$2,324
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$282
Novo Nordisk Inc
$258
GlaxoSmithKline, LLC.
$200
AstraZeneca Pharmaceuticals LP
$192
Otsuka America Pharmaceutical, Inc.
$145
Esperion Therapeutics, Inc.
$141
SANOFI-AVENTIS U.S. LLC
$125
Amgen Inc.
$59
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$50
Exact Sciences Corporation
$49
Boehringer Ingelheim Pharmaceuticals, Inc.
$43
Abbott Laboratories
$39
Bayer Healthcare Pharmaceuticals Inc.
$26
SCILEX PHARMACEUTICALS INC.
$23
Tactile Systems Technology Inc
$22
Radius Health, Inc.
$21
Phathom Pharmaceuticals, Inc.
$19
Xeris Pharmaceuticals, Inc.
$19
IDORSIA PHARMACEUTICALS US INC
$15
Astellas Pharma US Inc
$15
Top 3 companies account for 42.4% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$2,001
GlaxoSmithKline, LLC.
$1,986
AstraZeneca Pharmaceuticals LP
$1,354
Lilly USA, LLC
$1,074
Amgen Inc.
$1,003
Janssen Pharmaceuticals, Inc
$815
Boehringer Ingelheim Pharmaceuticals, Inc.
$813
Amarin Pharma Inc.
$641
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$637
AbbVie Inc.
$583
Bayer HealthCare Pharmaceuticals Inc.
$521
PFIZER INC.
$503
SANOFI-AVENTIS U.S. LLC
$416
Corcept Therapeutics
$311
Bayer Healthcare Pharmaceuticals Inc.
$237
Otsuka America Pharmaceutical, Inc.
$223
Sunovion Pharmaceuticals Inc.
$196
Astellas Pharma US Inc
$192
Esperion Therapeutics, Inc.
$162
Allergan Inc.
$158
Teva Pharmaceuticals USA, Inc.
$157
Lupin Inc.
$145
Merck Sharp & Dohme Corporation
$131
Ironwood Pharmaceuticals, Inc
$114
Takeda Pharmaceuticals U.S.A., Inc.
$96
AngioDynamics, Inc.
$87
Abbott Laboratories
$79
Exact Sciences Corporation
$68
Amneal Pharmaceuticals LLC
$65
E.R. Squibb & Sons, L.L.C.
$63
SANOFI PASTEUR INC.
$61
MannKind Corporation
$51
Celgene Corporation
$50
Becton, Dickinson and Company
$48
Synergy Pharmaceuticals Inc
$47
Allergan, Inc.
$46
Sanofi Pasteur Inc.
$44
Radius Health, Inc.
$41
Shield Therapeutics Inc
$41
Mannkind Corporation
$40
IRONWOOD PHARMACEUTICALS, INC
$34
Mylan Specialty L.P.
$29
Horizon Therapeutics plc
$26
Medtronic, Inc.
$24
SCILEX PHARMACEUTICALS INC.
$23
GENZYME CORPORATION
$23
Tactile Systems Technology Inc
$22
Philips Electronics North America Corporation
$21
ABBVIE INC.
$20
Metacel Pharmaceuticals LLC
$19
Noden Pharma USA Inc
$19
Phathom Pharmaceuticals, Inc.
$19
Xeris Pharmaceuticals, Inc.
$19
TherapeuticsMD, Inc.
$19
Novartis Pharmaceuticals Corporation
$18
Scilex Pharmaceuticals Inc.
$17
Seqirus USA Inc
$16
Eisai Inc.
$16
IDORSIA PHARMACEUTICALS US INC
$15
Horizon Pharma plc
$15
Janssen Biotech, Inc.
$15
Medtronic MiniMed, Inc.
$14
Cranial Technologies, Inc
$14
Biohaven Pharmaceuticals, Inc.
$13
Purdue Pharma L.P.
$12
Top 3 companies account for 33.8% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACCRUFER · ADVAIR · AFREZZA · AIRSUPRA · AJOVY · ANNOVERA · ANORO · ANORO ELLIPTA · APTIOM · AREXVY · Aimovig · BD Nano 2nd Gen Pen Needle · BEXSERO · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · Cologuard Collection Kit · DUEXIS · DUPIXENT · DUZALLO · Dayvigo · Doc Band · ELIQUIS · ELYXYB - CELECOXIB · EMGALITY · EUCRISA · EVENITY · FARXIGA · FASENRA · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FLUZONE HIGH-DOSE · FREESTYLE LIBRE 3 · Flexitouch Plus · Fluad · FreeStyle Libre · GEMTESA · INTELLIS ADAPTIVESTIM · INVOKANA · JANUVIA · JARDIANCE · KRYSTEXXA · Kerendia · Korlym · LEQVIO · LINZESS · LONHALA MAGNAIR · LUCEMYRA · LYRICA · LYVISPAH · Linzess · MOUNJARO · MOVANTIK · MYRBETRIQ · NEXLETOL · NEXLIZET · NO PRODUCT DISCUSSED · NURTEC ODT · Otezla · Ozempic · Ozobax · PENTACEL · PREMARIN · PREVNAR 13 · Prolia · QULIPTA · QUVIVIQ · RECORLEV · REXULTI · RYBELSUS · RYBREVANT · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · SOLOSEC · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · SYMPROIC · SYNTHROID · TEKTURNA · TEZSPIRE · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULANCE · TRULICITY · TZIELD · Tresiba · Trintellix · Trulance · Tymlos · UBRELVY · VIBERZI · VIIBRYD · VOQUEZNA · VRAYLAR · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · Xultophy 100/3.6 · Yupelri · ZTLido · iPro2
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for family medicine in CA.
Geographic Context
Family medicine physicians within 10 mi
362
Per 100K population
35.8
County median income
$71,434
Nearest hospital
FRESNO VA MEDICAL CENTER (VA CENTRAL CALIFORNIA HEALTHCARE SYSTEM)
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Castro is a clinical cardiology specialist, with above-average Medicare volume (top 24% in CA), with low-engagement industry engagement in the top 2% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Castro experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Castro performed 182 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Castro receive payments from pharmaceutical companies?
Yes. Dr. Castro received a total of $15,783 from 65 companies across 778 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Castro's costs compare to other family medicine physicians in Fresno?
Dr. Castro's average Medicare payment per service is $49. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Castro) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Fresno
Browse family medicine physicians in Fresno ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in CA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in CA
Which CA family medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology